Home About Us Technology Careers News Contact Us Log On

Cognition Therapeutics Inc.



Discovering small molecule therapeutics for Alzheimer's and other neurodegenerative diseases




Cognition Therapeutics welcomes inquiries from potential investors

Please contact Hank Safferstein at  412.770.1621
For more information on Alzheimer’s patient care, go to the Alzheimer Research Forum website




 

Logon

Access to Cognition Therapeutics servers


Login ID: 
Password:


 


Copyright © 2007—2011 Cognition Therapeutics, Inc.  All rights reserved.